Fancl Corp
TSE:4921
Fancl Corp
Capital Expenditures
Fancl Corp
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
F
|
Fancl Corp
TSE:4921
|
Capital Expenditures
-¥2.4B
|
CAGR 3-Years
33%
|
CAGR 5-Years
8%
|
CAGR 10-Years
0%
|
Shiseido Co Ltd
TSE:4911
|
Capital Expenditures
-¥56.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-10%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Capital Expenditures
-¥8.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-3%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Capital Expenditures
-¥16.2B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-8%
|
|
Kao Corp
TSE:4452
|
Capital Expenditures
-¥63.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Capital Expenditures
-¥13.6B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-15%
|
See Also
What is Fancl Corp's Capital Expenditures?
Capital Expenditures
-2.4B
JPY
Based on the financial report for Mar 31, 2024, Fancl Corp's Capital Expenditures amounts to -2.4B JPY.
What is Fancl Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
0%
Over the last year, the Capital Expenditures growth was -20%. The average annual Capital Expenditures growth rates for Fancl Corp have been 33% over the past three years , 8% over the past five years .